Home Epsilen Bio

Epsilen Bio

In operation
Seed Round Financing
Gene Therapy Technology Developer
Basic
Enterprise Profile

Basic Information

Epsilen Bio was founded in December 2019 and is headquartered in Milan, Italy. The company's mission is to develop transformative therapies for patients affected by underserved medical conditions through stable genomic epigenetic silencing of genes involved in disease processes.
EPSILEN Bio Srl
Milan,Lombardia,Italy
less than 15 people
December 01, 2019
info@epsilenbio.com

Enterprise Profile

Industrial Sector
New Drug Development Gene Therapy Production of Genetically Engineered Drugs
Technology
Gene Technology
Concept
Therapeutic Products Department of Pharmacy
Application Scenarios
Innovative Drugs Cell and Gene Therapy